THERAGEN ETEX CO.,LTD.
Founded in 1990 and listed on KOSDAQ in 2004, Theragen Etex operates pharmaceutical manufacturing and genomic analysis businesses.
As of 2026-10-11, THERAGEN ETEX CO.,LTD. has 430 Korean MFDS drug approvals, 55 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Products & technology
- Prescription drug distributionPrescription drug distribution via subsidiary Leadpharm
- Quasi-drug distributionQuasi-drug distribution via subsidiary Theragen Healthcare
- Genomic analysis serviceDNA sequencing and RNA variant genome analysis/decoding
Regulatory approvals
data.go.kr430 Korean MFDS drug approvals · 1985–2026
- MFDS drugTedoxaban Tab.30mg(Edoxaban Tosilat Hydrate)2026-08-31Drug · Prescription · Approval202602551
- MFDS drugTedoxaban Tab.15mg(Edoxaban Tosilat Hydrate)2026-08-31Drug · Prescription · Approval202602552
- MFDS drugTherachondroitin1200 oral gel2026-08-21Drug · OTC · Notification202602439
- MFDS drugPitagen ODT 2mg(Pitavastatin Calcium Hydrate)2026-07-30Drug · Prescription · Approval202602218
- MFDS drugPitagen ODT 4mg(Pitavastatin Calcium Hydrate)2026-07-30Drug · Prescription · Approval202602219
- MFDS drugTedoxaban Tab. 60mg2026-07-16Drug · Prescription · Approval202602062
- MFDS drugBestia-P Tab.2026-07-15Drug · OTC · Notification202602049
- MFDS drugRosuvazet ODT10/10mg(Ezetimibe/Rosuvastatin Calcium)2026-06-30Drug · Prescription · Approval202601867
- MFDS drugRosuvazet ODT10/20mg(Ezetimibe/Rosuvastatin Calcium)2026-06-30Drug · Prescription · Approval202601868
- MFDS drugRosuvazet ODT10/5mg(Ezetimibe/Rosuvastatin Calcium)2026-06-30Drug · Prescription · Approval202601869
- MFDS drugTerapelu Tab. 30mg (Pelubiprofen (micronized))2026-06-30Drug · Prescription · Approval202601905
- MFDS drugTegogen Tab. 25mg(Tegoprazan)2026-06-26Drug · Prescription · Approval202601817
Show 68 more
- MFDS drugTegogen Tab. 50mg(Tegoprazan)2026-06-26Drug · Prescription · Approval202601818
- MFDS drugRamothera Prefilled Inj.2026-04-06Drug · Prescription · Approval202600962
- MFDS drugPurantus tab(Pranlukast Hydrate)2026-01-15Drug · Prescription · Approval202600144
- MFDS drugPHILURATIN VAGINAL SOFT CAPSULE2026-01-13Drug · OTC · Notification202600111
- MFDS drugDulacto Syrup(Lactulose Concentrate)2026-01-06Drug · OTC · Notification202600042
- MFDS drugPanclitin Tab.2025-12-19Drug · OTC · Approval202503325
- MFDS drugGabamin SR Tab. 150mg(Rebamipide)2025-12-09Drug · Prescription · Approval202503221
- MFDS drugCitrin Tab.2025-11-07Drug · OTC · Notification202502894
- MFDS drugMemanzen Tab. 5mg2025-10-30Drug · Prescription · Approval202502817
- MFDS drugTheracalcidol Soft Cap 0.5mcg2025-10-27Drug · OTC · Notification202502753
- MFDS drugTheracalcidol Soft Cap 1mcg2025-10-27Drug · OTC · Notification202502754
- MFDS drugFenopita Tab.(Pitavastatin Calcium, Fenofibrate)2025-08-29Drug · Prescription · Approval202502271
- MFDS drugMinoxfeel Tab. (Minoxidil)2025-06-17Drug · Prescription · Approval202501471
- MFDS drugTheragenvitaZ Tab.2025-02-07Drug · OTC · Notification202500267
- MFDS drugInnodart Soft cap. 0.5mg2025-01-22Drug · Prescription · Approval202500167
- MFDS drugEtex Olmesartan Tab. 10mg2023-10-24Drug · Prescription · Approval202302975
- MFDS drugMonteragen tab 10/5mg(Montelukast,Levocetirizine)2023-09-12Drug · Prescription · Approval202302726
- MFDS drugEMPADIANG DUO12.5/850mg2023-08-30Drug · Prescription · Approval202302569
- MFDS drugEMPADIANG DUO12.5/1000mg2023-08-30Drug · Prescription · Approval202302570
- MFDS drugEMPADIANG DUO12.5/500mg2023-08-30Drug · Prescription · Approval202302571
- MFDS drugDapasitin Tab.(Dapagliflozin,Sitagliptin)2023-06-02Drug · Prescription · Approval202301736
- MFDS drugNewmaron Soft Capsule 0.5g2023-03-30Drug · Prescription · Approval202301080
- MFDS drugDukanagen Tab. 60/2.5mg2023-01-06Drug · Prescription · Approval202300110
- MFDS drugDukanagen Tab. 30/2.5mg2023-01-06Drug · Prescription · Approval202300131
- MFDS drugTheraNoPain2022-09-13Drug · OTC · Notification202203540
- MFDS drugS-amlomine Tab. 5mg(S-Amlodipine Besylate Dihydrate)2022-06-30Drug · Prescription · Approval202202691
- MFDS drugTeramet XR Tab. 50/500mg2022-05-13Drug · Prescription · Approval202202012
- MFDS drugTeramet XR Tab. 50/1000mg2022-05-13Drug · Prescription · Approval202202013
- MFDS drugTeramet XR Tab. 100/1000mg2022-05-13Drug · Prescription · Approval202202014
- MFDS drugEtex Sugammadex Sodium Injection2022-04-27Drug · Prescription · Approval202201720
- MFDS drugEMPADIANG DUO 5/1000mg2022-04-04Drug · Prescription · Approval202201395
- MFDS drugEMPADIANG DUO 5/850mg2022-04-04Drug · Prescription · Approval202201396
- MFDS drugEMPADIANG DUO 5/500mg2022-04-04Drug · Prescription · Approval202201397
- MFDS drugEtex Phloroglucinol Tab.2022-03-08Drug · Prescription · Approval202201014
- MFDS drugEtex Desmopressin Tab. 0.2 mg2022-01-06Drug · Prescription · Approval202200103
- MFDS drugEtex Desmopressin Tab. 0.1 mg2021-12-29Drug · Prescription · Approval202108188
- MFDS drugETEX EBASTINE Tab.2021-12-23Drug · Prescription · Approval202108095
- MFDS drugVera Tab.2021-11-04Drug · OTC · Notification202107320
- MFDS drugGinkgotop Tab. 240mg2021-11-04Drug · OTC · Notification202107322
- MFDS drugThedoxium Tab.(dobesilate calcium)2021-10-28Drug · Prescription · Approval202107191
- MFDS drugEtex Pantoprazole tab.(Pantoprazole Sodium Sesquihydrate)2021-10-25Drug · Prescription · Approval202107096
- MFDS drugEtex Rivastigmine Cap. 6.0mg2021-10-25Drug · Prescription · Approval202107099
- MFDS drugEtex Rivastigmine Cap. 4.5mg2021-10-25Drug · Prescription · Approval202107100
- MFDS drugTOPIMATE Tab.2021-10-12Drug · Prescription · Approval202106847
- MFDS drugEtex Buspirone Tab. 10mgRevoked2021-09-08Drug · Prescription · Approval202106424
- MFDS drugEtex Buspirone Tab. 5mgRevoked2021-09-06Drug · Prescription · Approval202106376
- MFDS drugEtex Afloqualone Tab.Revoked2021-08-30Drug · Prescription · Approval202106245
- MFDS drugFamotex Plus Tab.Revoked2021-08-19Drug · OTC · Notification202106050
- MFDS drugRuners Tab2021-08-10Drug · OTC · Notification202105831
- MFDS drugETEX NAPROXEN SODIUM Tab.Revoked2021-07-08Drug · OTC · Notification202105152
- MFDS drugEsomeet Tab. 20/800mg2021-06-18Drug · Prescription · Approval202104741
- MFDS drugTERACOXIB Tab.2021-04-27Drug · Prescription · Approval202103410
- MFDS drugHydone23mgRevoked2021-04-14Drug · Prescription · Approval202103091
- MFDS drugRivarox Tab. 10mg2021-03-26Drug · Prescription · Approval202102645
- MFDS drugRivarox Tab. 15mg2021-03-25Drug · Prescription · Approval202102594
- MFDS drugEMPADIANG 25mg2021-03-12Drug · Prescription · Approval202102282
- MFDS drugEMPADIANG 10mg2021-03-12Drug · Prescription · Approval202102283
- MFDS drugTerabia Tab. 50mg2021-02-24Drug · Prescription · Approval202101859
- MFDS drugTerabia Tab. 25mg2021-02-24Drug · Prescription · Approval202101860
- MFDS drugTerabia Tab. 100mg2021-02-24Drug · Prescription · Approval202101861
- MFDS drugWIPYEON Tab.2021-02-23Drug · OTC · Notification202101754
- MFDS drugZetisto tab 10/20mg2021-02-18Drug · Prescription · Approval202101635
- MFDS drugZetisto tab 10/10mg2021-02-18Drug · Prescription · Approval202101636
- MFDS drugZetisto tab 10/40mgRevoked2021-02-18Drug · Prescription · Approval202101634
- MFDS drugRivarox Tab. 20mg2021-01-12Drug · Prescription · Approval202100338
- MFDS drugEprenone 50mgRevoked2020-10-21Drug · Prescription · Approval202007207
- MFDS drugEprenone 25mgRevoked2020-10-21Drug · Prescription · Approval202007208
- MFDS drugCalciton Tab. 500/1000Revoked2020-10-12Drug · OTC · Notification202006937
Showing the 80 most recent of 430 records.
Clinical trials
data.go.kr45 MFDS clinical trial authorisations · 2013–2026 (Bioequivalence 43 · Phase 1 2)
- BioequivalenceTE232-042026-03-05
1 trial site
- BioequivalenceTE232-022025-07-10
1 trial site
- BioequivalenceTE232-022025-07-09
1 trial site
- BioequivalenceTE218-022025-06-23
1 trial site
- Phase 1페노피타정(페노피브레이트,피타바스타틴칼슘)2024-10-17
1 trial site
- Bioequivalence보노젠정20밀리그램(보노프라잔푸마르산염)2024-07-03
1 trial site
- Bioequivalence프로닐정(나프로닐옥살산염)2024-05-03
1 trial site
- Bioequivalence발트란정500mg(발라시클로비르염산염)2024-04-08
1 trial site
- Bioequivalence테독사반정60밀리그램(에독사반토실산염수화물)2024-02-27
1 trial site
- Bioequivalence테고젠정50밀리그램(테고프라잔)2023-10-26
1 trial site
- Bioequivalence메네신정(베타히스틴염산염)2023-05-15
1 trial site
- Bioequivalence이텍스피마사르탄정120밀리그램(피마사르탄칼륨삼수화물)(가칭)2022-01-04
1 trial site
Show 33 more
- Bioequivalence넥스온정20mg(에스오메프라졸마그네슘삼수화물)2021-12-13
2 trial sites
- Bioequivalence에페시나정(에페리손염산염)2021-12-10
1 trial site
- Phase 1다파글립틴정10/100밀리그램(가칭)2021-12-09
1 trial site
- Bioequivalence가바민정(레바미피드)2021-11-16
2 trial sites
- Bioequivalence테레신정2밀리그램(테라조신염산염수화물)2021-10-29
2 trial sites
- Bioequivalence넥스온정20mg(에스오메프라졸마그네슘삼수화물)2021-05-24
2 trial sites
- Bioequivalence라베졸정10mg(라베프라졸나트륨)2021-04-09
2 trial sites
- Bioequivalence테라카스정10mg(몬테루카스트나트륨)2020-12-02
1 trial site
- Bioequivalence이텍스올메사탄정20밀리그램(올메사탄메독소밀)2020-09-23
1 trial site
- Bioequivalence티피엠정(티로프라미드염산염)2020-08-06
2 trial sites
- Bioequivalence쎄레민캡슐(세레콕시브)2020-06-08
1 trial site
- Bioequivalence하이도네정10밀리그램(도네페질염산염)2020-05-20
1 trial site
- Bioequivalence클래로신정250밀리그램(클래리트로마이신)2020-03-18
2 trial sites
- Bioequivalence프라빅센정(클로피도그렐황산염)2019-12-04
1 trial site
- Bioequivalence에제스틴정10/20밀리그램2019-11-04
2 trial sites
- Bioequivalence라베졸정20mg(라베프라졸나트륨)2019-08-07
2 trial sites
- Bioequivalence테라콕시브정30밀리그램(에토리콕시브)2019-07-09
2 trial sites
- Bioequivalence라베졸정20mg(라베프라졸나트륨)2018-08-22
2 trial sites
- Bioequivalence넥스온정40mg2018-06-25
2 trial sites
- Bioequivalence엑스페라정10/160밀리그램2018-04-10
2 trial sites
- Bioequivalence이텍스로수바스타틴칼슘정10mg2017-07-13
2 trial sites
- Bioequivalence베포쎈정10mg2016-07-15
2 trial sites
- Bioequivalence리카스타캡슐(프레가발린)2015-12-03
2 trial sites
- Bioequivalence이텍스로수바스타틴칼슘정20mg2015-12-03
2 trial sites
- Bioequivalence올레온정2015-11-27
2 trial sites
- Bioequivalence타미렉스캡슐2015-11-26
2 trial sites
- Bioequivalence넥스온정40mg2015-11-25
2 trial sites
- Bioequivalence트라존정 (이트라코나졸)2015-11-19
2 trial sites
- Bioequivalence쎄레민캡슐(세레콕시브)2015-11-02
2 trial sites
- Bioequivalence아토센정20mg2015-03-10
2 trial sites
- Bioequivalence레녹신정2013-05-28
2 trial sites
- Bioequivalence라니젠정2013-01-24
2 trial sites
- Bioequivalence브로목틸정 40mg2013-01-24
2 trial sites
Key disclosures
KRX KIND via OpenDARTPublications
PubMed · affiliation-matched- Integrated-Omics Study on the Transcriptomic and Metabolic Changes of Bacillus licheniformis, a Main Microorganism of Fermented Soybeans, According to Alkaline pH and Osmotic Stress.
Journal of agricultural and food chemistry · 2023-10 · Park MK, Hong CP, Kim BS 외 2
- Effects of Single Nucleotide Polymorphisms and Mediterranean Diet in Overweight or Obese Postmenopausal Women With Breast Cancer Receiving Adjuvant Hormone Therapy: A Pilot Randomized Controlled Trial.
Frontiers in nutrition · 2022-01 · Cho AR, Hong KW, Kwon YJ 외 7
- Author Correction: Association between the relative abundance of gastric microbiota and the risk of gastric cancer: a case-control study.
Scientific reports · 2021-10 · Gunathilake MN, Lee J, Choi IJ 외 4
- Pre-Clinical Pharmacokinetic Characterization, Tissue Distribution, and Excretion Studies of Novel Edaravone Oral Prodrug, TEJ-1704.
Pharmaceutics · 2021-09 · Kang DW, Kim JH, Kim KM 외 7
- Identifi cation of the Underlying Genetic Factors of Skin Aging in a Korean Population Study.
Journal of cosmetic science · 2021-01 · Oh Kim J, Park B, Yoon Choi J 외 8
- Is hull cleaning wastewater a potential source of developmental toxicity on coastal non-target organisms?
Aquatic toxicology (Amsterdam, Netherlands) · 2020-10 · Choi Y, Kim M, Hong CP 외 2
- Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington's disease.
Cell proliferation · 2020-10 · Li E, Park HR, Hong CP 외 9
- Development of 18 microsatellite markers for Atractylodes japonica.
Applications in plant sciences · 2020-05 · Jeong JT, Chung H, Ha BK 외 10
- Loss of wild-type p53 promotes mutant p53-driven metastasis through acquisition of survival and tumor-initiating properties.
Nature communications · 2020-05 · Nakayama M, Hong CP, Oshima H 외 3
- Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
Cell proliferation · 2020-04 · Li L, Kim HJ, Roh JH 외 11
Show 45 more publications
- Changes in microbiome and metabolomic profiles of fecal samples stored with stabilizing solution at room temperature: a pilot study.
Scientific reports · 2020-02 · Lim MY, Hong S, Kim BM 외 3
- Neural Transplants From Human Induced Pluripotent Stem Cells Rescue the Pathology and Behavioral Defects in a Rodent Model of Huntington's Disease.
Frontiers in neuroscience · 2020-01 · Yoon Y, Kim HS, Hong CP 외 6
- Whole-genome, transcriptome, and methylome analyses provide insights into the evolution of platycoside biosynthesis in Platycodon grandiflorus, a medicinal plant.
Horticulture research · 2020-01 · Kim J, Kang SH, Park SG 외 18
- KRGDB: the large-scale variant database of 1722 Koreans based on whole genome sequencing.
Database : the journal of biological databases and curation · 2020-01 · Jung KS, Hong KW, Jo HY 외 4
- KRGDB: the large-scale variant database of 1722 Koreans based on whole genome sequencing.
Database : the journal of biological databases and curation · 2020-01 · Jung KS, Hong KW, Jo HY 외 4
- Association between the exposure to anti-angiogenic agents and tumour immune microenvironment in advanced gastrointestinal stromal tumours.
British journal of cancer · 2019-11 · Yoo C, Ryu YM, Kim SY 외 4
- A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) · 2019-10 · Kim YJ, Keam B, Ock CY 외 9
- Association between the relative abundance of gastric microbiota and the risk of gastric cancer: a case-control study.
Scientific reports · 2019-09 · Gunathilake MN, Lee J, Choi IJ 외 4
- Overlapping and unique toxic effects of three alternative antifouling biocides (Diuron, Irgarol 1051®, Sea-Nine 211®) on non-target marine fish.
Ecotoxicology and environmental safety · 2019-09 · Moon YS, Kim M, Hong CP 외 2
- Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer.
Clinical genitourinary cancer · 2019-06 · Xu Y, Kim YH, Jeong P 외 13
- Interleukin 1 Up-regulates MicroRNA 135b to Promote Inflammation-Associated Gastric Carcinogenesis in Mice.
Gastroenterology · 2019-03 · Han TS, Voon DC, Oshima H 외 12
- Comparative transcriptome analysis identified candidate genes involved in mycelium browning in Lentinula edodes.
BMC genomics · 2019-02 · Yoo SI, Lee HY, Markkandan K 외 7
- Urinary cell-free microRNA biomarker could discriminate bladder cancer from benign hematuria.
International journal of cancer · 2019-01 · Piao XM, Jeong P, Kim YH 외 14
- Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria.
Urologic oncology · 2019-01 · Xu Y, Kim YH, Jeong P 외 10
- Gene expression profiles alteration after infection of virus, bacteria, and parasite in the Olive flounder (Paralichthys olivaceus).
Scientific reports · 2018-12 · Nam GH, Mishra A, Gim JA 외 12
- Comparative transcriptome analyses of the third and fourth stage larvae of Anisakis simplex (Nematoda: Anisakidae).
Molecular and biochemical parasitology · 2018-12 · Kim JH, Kim JO, Jeon CH 외 4
- Data on transcriptome profiling of circulating microRNAs in dairy cattle.
Data in brief · 2018-12 · Markkandan K, Lim HJ, Lee DJ 외 5
- Repurposing the Cord Blood Bank for Haplobanking of HLA-Homozygous iPSCs and Their Usefulness to Multiple Populations.
Stem cells (Dayton, Ohio) · 2018-10 · Lee S, Huh JY, Turner DM 외 15
- Profiling and identification of pregnancy-associated circulating microRNAs in dairy cattle.
Genes & genomics · 2018-10 · Markkandan K, Ahn K, Lee DJ 외 6
- Identification of transposable elements fused in the exonic region of the olive flounder genome.
Genes & genomics · 2018-07 · Nam GH, Gim JA, Mishra A 외 7
- Identification of differentially expressed miRNAs and miRNA-targeted genes in bladder cancer.
Oncotarget · 2018-06 · Lee JY, Yun SJ, Jeong P 외 14
- Erratum: Identification of Epithelial-Mesenchymal Transition-related Target Genes Induced by the Mutation of Smad3 Linker Phosphorylation.
Journal of cancer prevention · 2018-06 · Park S, Yang KM, Park Y 외 16
- Association of PD-L1 Expression with Tumor-Infiltrating Immune Cells and Mutation Burden in High-Grade Neuroendocrine Carcinoma of the Lung.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2018-05 · Kim HS, Lee JH, Nam SJ 외 5
- Long-term health and germline transmission in transgenic cattle following transposon-mediated gene transfer.
BMC genomics · 2018-05 · Yum SY, Lee SJ, Park SG 외 13
- Successful application of human-based methyl capture sequencing for methylome analysis in non-human primate models.
BMC genomics · 2018-04 · Lee JR, Ryu DS, Park SJ 외 6
- Identification of Epithelial-Mesenchymal Transition-related Target Genes Induced by the Mutation of Smad3 Linker Phosphorylation.
Journal of cancer prevention · 2018-03 · Park S, Yang KM, Park Y 외 16
- Interactions among the variants of insulin-related genes and nutrients increase the risk of type 2 diabetes.
Nutrition research (New York, N.Y.) · 2018-03 · Hong KW, Kim SH, Zhang X 외 1
- Combined Mutation of Apc, Kras, and Tgfbr2 Effectively Drives Metastasis of Intestinal Cancer.
Cancer research · 2018-03 · Sakai E, Nakayama M, Oshima H 외 11
- An efficient and tunable parameter to improve variant calling for whole genome and exome sequencing data.
Genes & genomics · 2018-01 · Ahn YJ, Markkandan K, Baek IP 외 4
- Pathway profiles based on gene-set enrichment analysis in the honey bee Apis mellifera under brood rearing-suppressed conditions.
Genomics · 2018-01 · Kim K, Kim JH, Kim YH 외 2
- Long-read transcriptome data for improved gene prediction in Lentinula edodes.
Data in brief · 2017-12 · Park SG, Yoo SI, Ryu DS 외 5
- Structural Analysis of Recombinant Human Preproinsulins by Structure Prediction, Molecular Dynamics, and Protein-Protein Docking.
Genomics & informatics · 2017-12 · Jung SH, Kim CK, Lee G 외 2
- accD nuclear transfer of Platycodon grandiflorum and the plastid of early Campanulaceae.
BMC genomics · 2017-08 · Hong CP, Park J, Lee Y 외 5
- RNA seq- and DEG-based comparison of developmental toxicity in fish embryos of two species exposed to Iranian heavy crude oil.
Comparative biochemistry and physiology. Toxicology & pharmacology : CBP · 2017-06 · Jung JH, Ko J, Lee EH 외 5
- Development of 44 Novel Polymorphic SSR Markers for Determination of Shiitake Mushroom (Lentinula edodes) Cultivars.
Genes · 2017-03 · Lee HY, Moon S, Shim D 외 5
- Use of whole-exome sequencing to determine the genetic basis of signs of skin youthfulness in Korean women.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2017-03 · Chang YH, Shin YA, Kim JH 외 9
- Single nucleotide polymorphisms in exomes of high- and low-marbled meats in Korean cattle.
Animal genetics · 2016-12 · Shin S, Hong C, Song S 외 2
- Transcriptome Profiling and In Silico Analysis of the Antimicrobial Peptides of the Grasshopper Oxya chinensis sinuosa.
Journal of microbiology and biotechnology · 2016-11 · Kim IW, Markkandan K, Lee JH 외 4
- Aberrantly expressed microRNAs in the context of bladder tumorigenesis.
Investigative and clinical urology · 2016-06 · Lee JY, Ryu DS, Kim WJ 외 1
- Whole genome de novo sequencing and genome annotation of the world popular cultivated edible mushroom, Lentinula edodes.
Journal of biotechnology · 2016-04 · Shim D, Park SG, Kim K 외 11
- Identification of a possible susceptibility locus for UVB-induced skin tanning phenotype in Korean females using genomewide association study.
Experimental dermatology · 2015-12 · Kwak TJ, Chang YH, Shin YA 외 12
- Global Profiling of Various Metabolites in Platycodon grandiflorum by UPLC-QTOF/MS.
International journal of molecular sciences · 2015-11 · Lee JW, Ji SH, Kim GS 외 10
- Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation.
Nature genetics · 2015-11 · Kato N, Loh M, Takeuchi F 외 241
- Genomewide association study on chronic periodontitis in Korean population: results from the Yangpyeong health cohort.
Journal of clinical periodontology · 2015-08 · Hong KW, Shin MS, Ahn YB 외 2
- Characterization of Chromatin Structure-associated Histone Modifications in Breast Cancer Cells.
Genomics & informatics · 2012-09 · Hong CP, Choe MK, Roh TY
Patents
KIPRIS · applicant-matched- Subsidiary: (주)테라젠바이오신규한 폴리뉴클레오티드, 융합 단백질 및 이를 포함하는 암의 예방 또는 치료를 위한 약학 조성물
Published · 2025-11 · Application 1020250175727
- Subsidiary: (주)테라젠바이오METHOD AND DEVICE FOR DISTINGUISHING SOMATIC MUTATIONS AND ARTIFICIAL MUTATIONS IN DNA SEQUENCING DATA GENERATED FROM FORMALIN-FIXED PARAFFIN-EMBEDDED SAMPLES USING DEEP LEARNING
PCT · Published · 2025-02 · Application PCT/KR2025/001704
- Subsidiary: (주)테라젠바이오BARCODE-BASED METHOD FOR SCREENING NEOANTIGEN IMMUNOGENICITY
PCT · Published · 2024-11 · Application PCT/KR2024/096516
- Subsidiary: (주)테라젠바이오GENE AMPLIFICATION METHOD FOR PRODUCING IVT TEMPLATE
PCT · Published · 2024-11 · Application PCT/KR2024/096518
- Subsidiary: (주)테라젠바이오바코드 기반의 네오안티젠 면역원성 스크리닝 방법
Published · 2024-05 · Application 1020240064983
- Subsidiary: (주)테라젠바이오IVT 템플릿 제작을 위한 유전자 증폭 방법
Published · 2024-05 · Application 1020240065085
- Subsidiary: (주)테라젠바이오포르말린 고정 파라핀 포매된 샘플에서 생성된 DNA 시컨싱 데이터에서 딥러닝을 이용한 체세포 변이와 인공 변이의 구별 방법 및 이를 이용한 장치
Published · 2024-05 · Application 1020240059382
- Subsidiary: (주)테라젠바이오차세대 염기서열 분석을 이용한 C형 간염 바이러스 서열 검출 방법 및 시스템
Published · 2023-12 · Application 1020230189468
- Subsidiary: (주)테라젠바이오전사체 기반 유전자 발현값을 모방한 전사체 합성 방법 및 시스템
Published · 2023-12 · Application 1020230189469
- Subsidiary: (주)테라젠바이오CONSTRUCT COMPRISING UTR SEQUENCE THAT IMPROVES INTRACELLULAR STABILITY AND BIOSYNTHESIS OF MRNA AND USE THEREOF
US · Published · 2023-08 · Application 19109747
Show 99 more patents
- Subsidiary: (주)테라젠바이오CONSTRUCT COMPRISING UTR SEQUENCE THAT IMPROVES INTRACELLULAR STABILITY AND BIOSYNTHESIS OF MRNA AND USE THEREOF
EP · Published · 2023-08 · Application 23863409.1
- Subsidiary: (주)테라젠바이오CONSTRUCT COMPRISING UTR SEQUENCE THAT IMPROVES INTRACELLULAR STABILITY AND BIOSYNTHESIS OF MRNA AND USE THEREOF
PCT · Published · 2023-08 · Application PCT/KR2023/012989
- Subsidiary: (주)테라젠바이오METHOD AND DEVICE FOR DISTINGUISHING SOMATIC MUTATIONS AND ARTIFICIAL MUTATIONS IN DNA SEQUENCING DATA GENERATED FROM FORMALIN-FIXED PARAFFIN-EMBEDDED SAMPLES USING DEEP LEARNING
EP · Published · 2023-08 · Application 23900825.3
- Subsidiary: (주)테라젠바이오METHOD AND DEVICE FOR DISTINGUISHING SOMATIC MUTATIONS AND ARTIFICIAL MUTATIONS IN DNA SEQUENCING DATA GENERATED FROM FORMALIN-FIXED PARAFFIN-EMBEDDED SAMPLES USING DEEP LEARNING
PCT · Published · 2023-08 · Application PCT/KR2023/012761
- Subsidiary: (주)테라젠바이오METHOD AND COMPUTER PROGRAM FOR PREDICTING NEOANTIGENS BY PROCESSING LENGTHS OF PEPTIDES OF VARIOUS LENGTHS BY FOLDING
US · Published · 2023-08 · Application 19132680
- Subsidiary: (주)테라젠바이오METHOD AND COMPUTER PROGRAM FOR PREDICTING NEOANTIGENS BY PROCESSING LENGTHS OF PEPTIDES OF VARIOUS LENGTHS BY FOLDING
EP · Published · 2023-08 · Application 23894719.6
- Subsidiary: (주)테라젠바이오METHOD AND COMPUTER PROGRAM FOR PREDICTING NEOANTIGENS BY PROCESSING LENGTHS OF PEPTIDES OF VARIOUS LENGTHS BY FOLDING
PCT · Published · 2023-08 · Application PCT/KR2023/011701
- Subsidiary: (주)테라젠바이오mRNA의 세포내 안정성과 생합성을 향상시키는 UTR 서열을 포함하는 구성물과 그 사용
Registered · 2023-07 · Application 1020230097132
- Subsidiary: (주)테라젠바이오mRNA의 세포내 안정성과 생합성을 향상시키는 UTR 서열을 포함하는 구성물과 그 사용
Registered · 2023-07 · Application 1020230097135
- Subsidiary: (주)테라젠바이오IMMUNOGENICITY PREDICTION DEVICE, IMMUNOGENICITY PREDICTION METHOD AND COMPUTER PROGRAM FOR SYNTHETIC LONG PEPTIDE DESIGN
EP · Registered · 2023-05 · Application 23171753.9
- Subsidiary: (주)테라젠바이오IMMUNOGENICITY PREDICTION DEVICE, IMMUNOGENICITY PREDICTION METHOD AND COMPUTER PROGRAM FOR SYNTHETIC LONG PEPTIDE DESIGN
US · Published · 2023-04 · Application 18141239
- Subsidiary: (주)테라젠바이오포르말린 고정 파라핀 포매된 샘플에서 생성된 DNA 시컨싱 데이터에서 딥러닝을 이용한 체세포 변이와 인공 변이의 구별 방법 및 이를 이용한 장치
Registered · 2023-02 · Application 1020230022977
- Subsidiary: (주)테라젠바이오줄기세포의 유전성 안정성 예측을 위한 정보를 제공하는 방법
Registered · 2022-12 · Application 1020220187476
- Subsidiary: (주)테라젠바이오피부 마이크로바이옴을 이용한 맞춤형 화장품 평가 방법
Registered · 2022-12 · Application 1020220187281
- Subsidiary: (주)테라젠바이오다양한 길이의 펩타이드의 길이를 접힘으로 처리하여 신항원을 예측하는 방법 및 컴퓨터 프로그램
Registered · 2022-11 · Application 1020220160675
- Subsidiary: (주)테라젠바이오mRNA의 세포내 안정성과 생합성을 향상시키는 UTR 서열을 포함하는 구성물과 그 사용
Registered · 2022-09 · Application 1020220114207
- Subsidiary: (주)테라젠바이오합성 긴 펩타이드의 면역원성 예측 장치, 면역원성 예측 방법 및 컴퓨터 프로그램
Registered · 2022-08 · Application 1020220105655
- Subsidiary: (주)테라젠바이오유소년기 얼굴성장 패턴 분류 기술 개발 및 연관 유전자 정보 발굴
Registered · 2022-04 · Application 1020220044353
- Subsidiary: (주)테라젠바이오줄기세포의 배양적응성을 판단하기 위한 체세포 변이를 선별하는 방법
Registered · 2021-12 · Application 1020210178182
- Subsidiary: (주)테라젠바이오차세대 염기서열 분석 기술 기반 COVID-19 진단 및 변이체 판정 시스템
Registered · 2021-11 · Application 1020210154442
- Subsidiary: (주)테라젠바이오분자 아형 산출 장치, 질환에 대한 분자 아형 개수를 산출하는 방법 및 상기 방법을 실행하기 위한 컴퓨터 프로그램
Registered · 2021-10 · Application 1020210140494
- Subsidiary: (주)테라젠바이오METHOD FOR DETERMINING PERSONAL SKIN TYPE, AND METHOD AND SYSTEM FOR PROVIDING CUSTOMIZED COSMETICS BASED THEREON
PCT · Published · 2021-10 · Application PCT/KR2021/013853
- Subsidiary: (주)테라젠바이오HLA 클래스 I 또는 II 대립유전자와 다양한 길이의 펩타이드를 대상으로 신생항원을 예측하는 방법 및 컴퓨터 프로그램
Registered · 2021-03 · Application 1020210032131
- Subsidiary: (주)테라젠바이오METHOD AND COMPUTER PROGRAM FOR PREDICTING NEOANTIGEN BY USING PEPTIDE SEQUENCE AND HLA ALLELE SEQUENCE
US · Published · 2020-12 · Application 17909866
- Subsidiary: (주)테라젠바이오METHOD AND COMPUTER PROGRAM FOR PREDICTING NEOANTIGEN BY USING PEPTIDE SEQUENCE AND HLA ALLELE SEQUENCE
EP · Published · 2020-12 · Application 20926771.5
- Subsidiary: (주)테라젠바이오METHOD AND COMPUTER PROGRAM FOR PREDICTING NEOANTIGEN BY USING PEPTIDE SEQUENCE AND HLA ALLELE SEQUENCE
PCT · Published · 2020-12 · Application PCT/KR2020/019017
PCT · Published · 2020-11 · Application PCT/KR2020/017088
- Subsidiary: (주)테라젠바이오개인정보를 보호하기 위한 유전체 데이터 비식별화 처리 장치, 유전체 데이터를 비식별화 처리한 비식별 유전 데이터를 생성하는 방법 및 컴퓨터 프로그램
Registered · 2020-11 · Application 1020200148142
- Subsidiary: (주)테라젠바이오대상 암 조직 및 세포 유리형 DNA 유래 펩타이드 서열 및 HLA 클래스 II 대립유전자 서열을 이용하여 신생항원을 예측하는 방법 및 컴퓨터 프로그램
Registered · 2020-09 · Application 1020200119331
- Subsidiary: (주)테라젠바이오원발 부위 예측 장치, 사용자의 유전체 데이터를 이용하여 원발 부위를 예측하는 방법 및 컴퓨터 프로그램
Registered · 2020-06 · Application 1020200076756
- Subsidiary: (주)테라젠바이오바이러스 치료를 위한 면역원을 예측하는 방법 및 컴퓨터 프로그램
Registered · 2020-04 · Application 1020200042975
- Subsidiary: (주)테라젠바이오생체시료 보존용 마스크 및 이를 이용한 호흡기 바이러스 또는 구강 미생물의 검출 방법 및 모니터링 시스템
Withdrawn · 2020-04 · Application 1020200041080
- Subsidiary: (주)테라젠바이오펩타이드 서열 및 HLA 대립유전자 서열을 이용하여 신생항원을 예측하는 방법 및 컴퓨터 프로그램
Registered · 2020-03 · Application 1020200035815
- Subsidiary: (주)테라젠바이오유전자 분석 데이터 및 생활습관 데이터 기반의 개인 맞춤형 헬스케어 시스템
Registered · 2020-03 · Application 1020200032281
- Subsidiary: (주)테라젠바이오비만 진단용 조성물, 키트, 및 이를 이용한 개체의 비만 관리 방법
Rejected · 2019-12 · Application 1020190179812
Withdrawn · 2019-11 · Application 1020190156021
CN · Published · 2019-09 · Application 201980060850.1
US · Registered · 2019-09 · Application 17276351
EP · Published · 2019-09 · Application 19861613.8
PCT · Published · 2019-09 · Application PCT/KR2019/011639
- Subsidiary: (주)테라젠바이오특정 약물의 타겟 유전자와 관련된 시그니처를 기초로 타겟 유전자와 관련된 유전자들을 판단하는 전자 장치, 방법 및 상기 방법을 실행하기 위한 컴퓨터 프로그램
Registered · 2019-08 · Application 1020190101129
US · Published · 2019-05 · Application 16413014
- Subsidiary: (주)테라젠바이오생체정보 측정시스템 및 그 방법
Registered · 2019-05 · Application 1020190051912
Expired · 2018-09 · Application 1020180111079
Registered · 2018-06 · Application 1020180072936
Registered · 2018-06 · Application 1020180069060
- Subsidiary: (주)테라젠바이오유전자 분석 장치 및 이를 이용한 유전자 분석 방법
Rejected · 2018-05 · Application 1020180062896
Rejected · 2017-11 · Application 1020170152172
Rejected · 2017-11 · Application 1020170152171
Rejected · 2017-11 · Application 1020170152173
Rejected · 2017-03 · Application 1020170029749
Registered · 2017-02 · Application 1020170018286
PCT · Published · 2016-11 · Application PCT/KR2016/013828
Expired · 2016-11 · Application 1020160152231
Registered · 2016-04 · Application 1020160045807
Registered · 2014-02 · Application 1020140024262
PCT · Published · 2014-02 · Application PCT/KR2014/001704
Registered · 2014-02 · Application 1020140017478
Registered · 2014-02 · Application 1020140017475
Registered · 2013-08 · Application 1020130095143
Registered · 2013-07 · Application 1020130087671
PCT · Published · 2012-11 · Application PCT/KR2012/009361
PCT · Published · 2012-11 · Application PCT/KR2012/009360
Registered · 2012-10 · Application 1020120113514
Registered · 2012-10 · Application 1020120113513
Registered · 2012-01 · Application 1020120003944
Withdrawn · 2011-12 · Application 1020110129099
Expired · 2011-03 · Application 1020110022442
Rejected · 2011-03 · Application 1020110022443
Registered · 2009-05 · Application 1020090045011
- Subsidiary: 리드팜(주)혈당 강하용 생약 조성물
Rejected · 2008-06 · Application 1020080052561
- Subsidiary: 리드팜(주)혈당 강하용 식품 조성물
Expired · 2007-10 · Application 1020070101381
EP · Registered · 2007-05 · Application 07746641.5
Registered · 2006-12 · Application 1020060120563
Expired · 2006-03 · Application 2020060007235
Rejected · 2005-12 · Application 1020050130448
Abandoned · 2005-12 · Application 1020050130447
Rejected · 2005-03 · Application 1020050024223
Abandoned · 2005-03 · Application 1020050024221
Expired · 2004-07 · Application 1020040054776
Rejected · 2004-07 · Application 1020040054686
Expired · 2004-07 · Application 1020040054777
Rejected · 2004-07 · Application 1020040051959
Expired · 2004-06 · Application 1020040047537
Expired · 2004-06 · Application 1020040044531
Expired · 2003-08 · Application 1020030060605
Rejected · 2003-08 · Application 1020030060604
Expired · 2003-08 · Application 1020030060603
Expired · 2003-06 · Application 2020030018752
Expired · 2003-03 · Application 1020030018993
Expired · 2003-01 · Application 1020030006441
Expired · 2003-01 · Application 1020030006375
Expired · 2002-08 · Application 1020020052240
Expired · 2001-06 · Application 2020010018981
Expired · 2001-06 · Application 2020010018980
Rejected · 2001-06 · Application 1020010036180
Expired · 1998-06 · Application 2019980009990
Expired · 1998-06 · Application 2019980009991
Expired · 1997-02 · Application 2019970001934
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive7
- OpenAIOAI-SearchBot74
- GoogleGoogleOther4
- PerplexityPerplexityBot2
- AnthropicClaudeBot2
- MicrosoftBingbot1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 10, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for THERAGEN ETEX CO.,LTD. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies in the same categoryPharma & CDMO
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.
Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition